Google TrendGME (1000+) — GameStop Stock Hits a New 52-Week High: What's Going On?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "EGFR-STAT1 pathway drives" (23 stories)

Top Headline Story

EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases
Lead StoryNaturegeneral
Oct 9, 2025

EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE43X3ZKR3ZKdlRZLTlreTUtSlRpZ25IazAwQ2ZOeDlOYk1zRlEwUmdOeUFXUHcyZktFVk1sbEU1a25EQjF3TnhzeHJvUXB4QWo5eDVpWmQ1b0s2U3BiQlJz?oc=5" target="_blank">EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
1000+19m ago

gme

GameStop Stock Hits a New 52-Week High: What's Going On?

200+19m ago

pope francis

The Myth of St. Francis

500+29m ago

nicolò tresoldi

Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League

1000+29m ago

michael olise

The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu

Search Results for "EGFR-STAT1 pathway drives"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

22 stories displayed
Reversing Fibrosis: New Research Provides Insight for Novel Therapies
Yale School of Medicinegeneral

Reversing Fibrosis: New Research Provides Insight for Novel Therapies

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQUWtCc3Z5R3pZNjlKUXlfY3R3ZHFGcVktbWVHSGhMbWl5dmZyd1JkSlZsRjRibjJqZnZacXRRb2JhU1phNE5RRFZnaHdtVTZXX09oRkdCdWs4a3VsVkJGY2NWNmFzYzJyOEcyTk1lcEU5X2swVktycEkwMndEeXJMdDdaenJNWkQwX2RLU1R6eW1FVmpRVmRkQ1YyXy1sUUhyQkYzREhJaGQyOUx3?oc=5" target="_blank">Reversing Fibrosis: New Research Provides Insight for Novel Therapies</a>  <font color="#6f6f6f">Yale School of Medicine</font>

IGSF10 regulates osteogenesis and osteoclastogenesis via a noncanonical EGFR–STAT1 signaling axis to promote skeletal regeneration
Naturegeneral

IGSF10 regulates osteogenesis and osteoclastogenesis via a noncanonical EGFR–STAT1 signaling axis to promote skeletal regeneration

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1MNTZJWGlqT3RQMjVhTTZtSE5XVDJ5LTQyYTNfOWdydnlQZm5OczNPNXBSOU1xQTlOYndNRnJxbjJfQWt3YlVWZmpjOVE2djlKOUI3aUV3TVVDNjc1a0lV?oc=5" target="_blank">IGSF10 regulates osteogenesis and osteoclastogenesis via a noncanonical EGFR–STAT1 signaling axis to promote skeletal regeneration</a>  <font color="#6f6f6f">Nature</font>

The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications
Wiley Online Librarygeneral

The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5oOXNibjlaV2hmb2JwNThONTFPZjYyb0lSR09JWnZ6OTBDX3o3RFBGbW1INDhVX0pFVUZCc0p5OVZNVGJjQko5S2ctNVhUWGpfTTdOaUwtd1FRWEt6bml0eWxGVHp1cVlMY2E4?oc=5" target="_blank">The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications</a>  <font color="#6f6f6f">Wiley Online Library</font>

Redox regulation of EGFR activation by thioredoxin reductase 3 drives resistance to EGFR inhibitors in triple-negative breast cancer
Naturegeneral

Redox regulation of EGFR activation by thioredoxin reductase 3 drives resistance to EGFR inhibitors in triple-negative breast cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zYXRHYVVuRVlPM0JPZXlKa2xrOTdIVDFuSksxQ1hQUlpYVWI2bGFYSWJYOXpVMnRuTFYzWS1rbFplQUNtQ3JIbjluNzJQeDRCdVliWlNISmxoMEhLczhz?oc=5" target="_blank">Redox regulation of EGFR activation by thioredoxin reductase 3 drives resistance to EGFR inhibitors in triple-negative breast cancer</a>  <font color="#6f6f6f">Nature</font>

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C–mutant non-small cell lung cancer
Natureworld

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C–mutant non-small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1RY2dXWFIzclhxXzE3dTA0bkpYNHNMMmhtZGhhTm9lMU5CZUZqcjlGX3MxTW9pYmY3Vi1KcVJqY3BoTzBrcTFIZHdtbWVGaVJVeWRkTjFwZlBSb0VwR3Nr?oc=5" target="_blank">Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C–mutant non-small cell lung cancer</a>  <font color="#6f6f6f">Nature</font>

PLSCR1 drives chemoresistance in TNBC via METTL3/IGF2BP3-mediated mRNA stabilization and EGFR-MAPK pathway activation
Naturegeneral

PLSCR1 drives chemoresistance in TNBC via METTL3/IGF2BP3-mediated mRNA stabilization and EGFR-MAPK pathway activation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0xX09KTWlJWXF3dEJsTUgxam9kdEl6Y1IybEJ4RlQtNi11Q1Z6VWwyVkNLOXVFcTVxQUkwR0NOMlBOTWRlN2VwRHR6dVVaU3pSZW5GbHFyRWEtM1c5YU13?oc=5" target="_blank">PLSCR1 drives chemoresistance in TNBC via METTL3/IGF2BP3-mediated mRNA stabilization and EGFR-MAPK pathway activation</a>  <font color="#6f6f6f">Nature</font>

MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer
Naturegeneral

MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Bc0FRZ0ZQR3Y4d3o3LWVPb0FMeng1UWRndUZfWjIwZS1DeEhIb0RkenZTZlRnbDhlYk1tQjVka25hOW1rcGtkYXNMaC1MZmRkQU1BQmlhMktYczVRQmU4?oc=5" target="_blank">MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer</a>  <font color="#6f6f6f">Nature</font>

PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways
Natureworld

PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1yYmM5TmNzdXpiTnJJWTJlb2dWX05lOUNuWjhJVGNQZ0pSZVQxVk5qTWsxd1hJbkRQUk1qRGxLdFh4c1VqOFBUWklYQS1qT0Z3OWJ0VTkyeUtwczRLdUtZ?oc=5" target="_blank">PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways</a>  <font color="#6f6f6f">Nature</font>

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer
Natureworld

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE53eG43Vkxpb0FNbDZPU1pMVEthRTROMnhtRlZYZm1JVWU5ZG1LQ2pSYXV6dEdnLTFMVE91ZWdrSjEtY2FXbkVMMzBrVGNmbFJ5UjAzZVJlWFV2N0pHam1V?oc=5" target="_blank">MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer</a>  <font color="#6f6f6f">Nature</font>

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Natureworld

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5WMUFYbG54UG1fUnhoY3gyV0NtblBwdFEySTk5czRzalhkWkdGbGtxc3VlZ3hFTV9zUUY3bzZETjdxQkJwZGJmLVI4SWFLU3JUb09BM2s5WGpNZDFOQlRZ?oc=5" target="_blank">Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer</a>  <font color="#6f6f6f">Nature</font>

A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer
Natureworld

A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1ORHFHWTE3dUlGXzVNU1k2dzhKenNmaGJDVkwxRUN1bzZQRGItMnk2cE9KU0Y4Z2VVV1lYT3pVdGVCb20wMEFBRDY5N19UcWpEOTdfejhHaVhsaGllb1Zz?oc=5" target="_blank">A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer</a>  <font color="#6f6f6f">Nature</font>

E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer
Naturegeneral

E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0taHJaRm1udzU1SzduWVk0VzdIUFlWTFBZVl91ZHEwMkFReW9QdC1KWGdTYkNSRktUY1FkWEV4NW1pVDJuM21LR3FVSVdad0VVMkQ4ZmI0LVJPcTVtbmVn?oc=5" target="_blank">E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer</a>  <font color="#6f6f6f">Nature</font>

ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling
Naturegeneral

ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE15NWFtVW1oaC0yenB6RlVEelh3LXlDT2MxbUxCZlNBejFBNU1kZ3gxdzRVLVlwRFFwZDlNYnhSOVMyQzc5VjYyOGlDTkNGb3RrZzc0amt6T0JnN2NVT1Fv?oc=5" target="_blank">ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling</a>  <font color="#6f6f6f">Nature</font>

TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway
Natureworld

TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE53RjlFdF80eGp1VnRBVDhXTVY0NU5IQVljWVpDdmpDSEZaSFZaZ1ZYSFFfaTFfb1JmVGFncE9TMWNPY2h0RVpmQXlkQ25Qd1FGRTA5Ui1ma2xnNXotYW5V?oc=5" target="_blank">TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway</a>  <font color="#6f6f6f">Nature</font>

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Naturegeneral

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBhODQyd3RLVExqZ2h3Rk9aUGZFczF2ajZoZVlWMFN0STdHbXdIdnp4LW4wVURUdTI5QVU1QTVYLWNqZTNBMWtYSTlPWEg5N1FESlNnQWdpYUdFTWZzZVJr?oc=5" target="_blank">Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy</a>  <font color="#6f6f6f">Nature</font>

EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis
Natureworld

EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9pUGtaMlZYeFZ4bkJUVGRIQ21zM2g0SldVcWRCaURmekpld2FQVFlsVU54NDBYQWY2ZmJONjVQaFh3cGVEWVJwQkRsR2U4NnZiS1puLTFHbDVEQzJtLVZr?oc=5" target="_blank">EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-Fos-MDK-LRP1 axis</a>  <font color="#6f6f6f">Nature</font>

Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand
Naturegeneral

Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9DR3lLazBTekVzNkhYbzM0dnR0ZTNjSmJaTmR3dFhLZG5vRkNxUmNJY2NCQjFlaVU1bVQtN3Vwa1lIOWF0Tm1nb2YwMDlfUzFDM0ZaVWhXZWRPMXQxTkE?oc=5" target="_blank">Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand</a>  <font color="#6f6f6f">Nature</font>

Glioblastoma at the crossroads: current understanding and future therapeutic horizons
Natureworld

Glioblastoma at the crossroads: current understanding and future therapeutic horizons

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zRHhsNTNpNzgtdlJNLUxJNXVHdFdGSWVEUEhGbHdOUFNUakpKSS1BYkJvNDBQa1Y4SDNCUE02eFhXUVhIalc1Z1daNGxDcmtZVWdnZ1pMeFBMRWxOajZv?oc=5" target="_blank">Glioblastoma at the crossroads: current understanding and future therapeutic horizons</a>  <font color="#6f6f6f">Nature</font>

EGFR-dependent TOR-independent endocycles support Drosophila gut epithelial regeneration
Naturegeneral

EGFR-dependent TOR-independent endocycles support Drosophila gut epithelial regeneration

<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE5EbElBV2t0NFU4OGFWdUhFd3pTczNZRm1TRmt3VWZHMWxaR3NxUHQtcHJWOFphalRUajBZQkM0UElQSW5qOGp4NzNfMklNeHBNMEtzbEpB?oc=5" target="_blank">EGFR-dependent TOR-independent endocycles support Drosophila gut epithelial regeneration</a>  <font color="#6f6f6f">Nature</font>

Signal transducer and activator of transcription-3 drives the high-fat diet-associated prostate cancer growth
Naturegeneral

Signal transducer and activator of transcription-3 drives the high-fat diet-associated prostate cancer growth

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE1MVXc5NTNyaGIzcUU2N2UySWtMNFE4OFlFalpwRjUyYnVXMmZmUUdyejRZTnI2Y3lLRHA3ZDdvbm1QV3JTalBMY0tSZU5jS2dobFA4ekhCRHFzaFFKU2c?oc=5" target="_blank">Signal transducer and activator of transcription-3 drives the high-fat diet-associated prostate cancer growth</a>  <font color="#6f6f6f">Nature</font>

Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration
Naturegeneral

Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFB1XzBCbzVMZmFCanl5ZzJvUmk3R0hFb1NZZEpqNmhsbWZEdk9JLVlqWG5WTUdTYnpTNGRQd1VSUGFuaDJEa3A1UGNqZW5KVUZmYlhv?oc=5" target="_blank">Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration</a>  <font color="#6f6f6f">Nature</font>

Accumulation of differentiating intestinal stem cell progenies drives tumorigenesis
Naturegeneral

Accumulation of differentiating intestinal stem cell progenies drives tumorigenesis

<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1faHJhUDRRTUN6SGc5YXNVX2thWXZUUUZOY211UlhRRU5yckhybHIteHNHbVhWZkxhb1ZCdmV2bXhGQ3Q1RW5nd0NLNmhqWFFqRjZtalJB?oc=5" target="_blank">Accumulation of differentiating intestinal stem cell progenies drives tumorigenesis</a>  <font color="#6f6f6f">Nature</font>

"EGFR-STAT1 pathway drives" — Live Google News Trends & Headlines